Related Experiment Video
Updated: May 19, 2026
12:45
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Cardiac resynchronization therapy: a breakthrough in heart failure management
M Ståhlberg1, L H Lund, S Zabarovskaja
1Department of Cardiology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
Journal of Internal Medicine
|August 14, 2012
Summary
Cardiac resynchronization therapy (CRT) effectively overcomes detrimental effects of heart failure dyssynchrony. This therapy synchronizes ventricular contractions, improving cardiovascular function in patients with electrical and mechanical dyssynchrony.
Area of Science:
- Cardiology
- Biomedical Engineering
- Electrophysiology
Background:
- Heart failure is a widespread epidemic.
- Electrical and mechanical dyssynchrony, indicated by QRS prolongation on ECG, negatively impacts the cardiovascular system.
- This dyssynchrony is a significant complication in heart failure patients.
Purpose of the Study:
- To provide a comprehensive overview of cardiac resynchronization therapy (CRT).
- To discuss the rationale and evidence supporting CRT efficacy.
- To address gender-specific effects, patient follow-up, and unresolved issues in CRT.
Main Methods:
- Review of existing studies and clinical data on CRT.
- Analysis of the mechanisms by which CRT counteracts cardiac dyssynchrony.
- Discussion of therapeutic strategies and patient selection for CRT.
Main Results:
- CRT has demonstrated significant efficacy in overcoming adverse effects of cardiac dyssynchrony.
- Simultaneous or near-simultaneous stimulation of both ventricles improves cardiovascular outcomes.
- Evidence supports CRT as a valuable therapeutic option for selected heart failure patients.
Conclusions:
- Cardiac resynchronization therapy (CRT) is a proven intervention for heart failure patients with dyssynchrony.
- Further research is needed to optimize CRT strategies and address gender-specific responses and long-term outcomes.
- CRT represents a significant advancement in managing the complications of heart failure.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...